Safety and Immunogenicily of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B Gag/pol/nef Vaccine in Healthy Adults

Autor: Priddy, Frances H., Brown, Deborah, Kublin, James, Monahan, Kathleen, Wright, David P., Lalezari, Jacob, Santiago, Steven, Marmor, Michael, Lally, Michelle, Novak, Richard M., Brown, Stephen J., Kulkarni, Priya, Dubey, Sheri A., Kierstead, Lisa S., Casimiro, Danilo R., Mogg, Robin, DiNubile, Mark J., Shiver, John W., Leavitt, Randi Y., Robertson, Michael N., Mehrotra, Devan V., Quirk, Erin

Publikováno v: Clinical Infectious Diseases, 2008 Jun 01. 46(11), 1769-1781.

Externí odkaz: https://www.jstor.org/stable/40307489

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Phase III Comparative Study of the Efficacy and Tolerability of Three Non-Nucleoside Reverse Transcriptase Inhibitor-Sparing Antiretroviral Regimens for Treatment-Naïve HIV-1-Infected Volunteers: A Randomized, Controlled Trial

Autor: Lennox, Jeffrey L., Landovitz, Raphael J., Ribaudo, Heather J., Ofotokun, Ighovwerha, Na, Lumine H., Godfrey, Catherine, Kuritzkes, Daniel R., Sagar, Manish, Brown, Todd T., Cohn, Susan E., McComsey, Grace A., Aweeka, Francesca, Fichtenbaum, Carl J., Presti, Rachel M., Koletar, Susan L., Haas, David W., Patterson, Kristine B., Benson, Constance A., Baugh, Bryan P., Leavitt, Randi Y., Rooney, James F., Seekins, Daniel, Currier, Judith S.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7fa4cf56951b9cc07eafd9e29876c854
https://europepmc.org/articles/PMC4412467/

Randomized, double-blind trial comparing indinavir alone, zidovudine alone and indinavir plus zidovudine in antiretroviral therapy-naive hiv-infected individuals with CD4 cell counts between 50 and 250/mm3

Autor: LEWI, David S., SULEIMAN, Jamal M., UIP, David E., PEDRO, Rogerio J., SOUZA, Rosa A., SULEIMAN, Grace S., ACCETTURI, Conceição, LEITE, Olavo M., ABREU, William B., KALICHMAN, Artur O., MORAES-FILHO, Joaquim P.P., MOTTI, Eduardo F., PECORARO, Maria Lucia C., MAKURATH, Mark R., NESSLY, Michael L., LEAVITT, Randi Y.

Publikováno v: Revista do Instituto de Medicina Tropical de São Paulo; Vol. 42 No. 1 (2000); 27-36
Revista do Instituto de Medicina Tropical de São Paulo; Vol. 42 Núm. 1 (2000); 27-36
Revista do Instituto de Medicina Tropical de São Paulo; v. 42 n. 1 (2000); 27-36
Revista do Instituto de Medicina Tropical de São Paulo
Instituto de Medicina Tropical (IMT)
instacron:IMT
Revista do Instituto de Medicina Tropical de São Paulo, Volume: 42, Issue: 1, Pages: 27-36, Published: FEB 2000

Treatment with indinavir has been shown to result in marked decreases in viral load and increases in CD4 cell counts in HIV-infected individuals. A randomized double-blind study to evaluate the efficacy of indinavir alone (800 mg q8h), zidovidine alo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4961a4ff71acc0adc5ca0f33d59b5e6b
https://www.revistas.usp.br/rimtsp/article/view/30404

Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257.

Autor: Ofotokun, Ighovwerha, Na, Lumine H., Landovitz, Raphael J., Ribaudo, Heather J., McComsey, Grace A., Godfrey, Catherine, Aweeka, Francesca, Cohn, Susan E., Sagar, Manish, Kuritzkes, Daniel R., Brown, Todd T., Patterson, Kristine B., Para, Michael F., Leavitt, Randi Y., Villasis-Keever, Angelina, Baugh, Bryan P., Lennox, Jeffrey L., Currier, Judith S.

Publikováno v: Clinical Infectious Diseases; 6/15/2016, Vol. 62 Issue 12, p1842-1851, 10p